Clinical trial success rates by therapeutic area 2020

Published by
Matej Mikulic,
Jun 1, 2022
The probability that a cancer drug will make it from phase I to final approval stood at some 2.4 percent, according to a study published in March 2020. The data is based on clinical success rate models from 2014, 2016, and 2019. Once a cancer drug made it into phase III, the chances to make it to final approval increased to 35.5 percent.

Clinical trial success rates by therapeutic area as of 2020*

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

March 2020

Region

United States

Survey time period

as of March 2020

Supplementary notes

* Rates across all indications for individual therapeutic agents (as opposed to rates for lead indications, which were higher in all phases). Only the success rates used in this analysis were reported.
All values are based on three models on clinical trial success by Wong et al. (2019), Thomas et al. (2016), and Hay et al. (2014).

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Clinical trials "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Clinical trials

R&D overview

6

Top R&D companies

5

Clinical studies

7

Participation

4

Costs and market

6

Approvals, launches, setbacks

6

COVID-19

4

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Clinical trialsGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsCoronavirus (COVID-19) vaccines and treatments
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.